New measures studied to boost substitute drug dispensing
Published: 2003-05-21 07:00:00
Updated: 2003-05-21 07:00:00
A set of new measures that would greatly expand the basis for substitute drug dispensing via compulsory verification of efficacy equivalence on drugs whose bioequivalence testing is exempted and/or unnecessary, the Korea Food and Drug Administration said recently.
The KFDA said there are about...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
